Illumina receives first FDA emergency use authorization for an RNA sequencing-based COVID-19 diagnostic test

June 11, 2020 Leave a comment 2,129 Views

Illumina, Inc. is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: COVIDSeq

Illumina receives first FDA emergency use authorization for an RNA sequencing-based COVID-19 diagnostic test

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit

SiT – spatial isoform transcriptomics

Analysis of single-cell rna-seq data

AllenDigger – spatial expression data visualization, spatial heterogeneity delineation, and single-cell registration based on the Allen Brain Atlas

New research identifies an inaccuracy in the single cell GENCODE gene model